0954-6634

Journal of Dermatological Treatment

Informa UK (Taylor & Francis)

View prefix report (10.3109)

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 141 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact141 DOIs
2

Attach ORCID iDs across 141 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact141 DOIs
3

Add license metadata to 140 records

License metadata tells indexers and readers how each article may be reused.

High impact140 DOIs

DOIs for this ISSN

Showing the top 5 of 141 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Superior efficacy of calcipotriene and betamethasone dipropi… (10.3109/09546634.2015.1083935)
Abstract ORCID License
149.67 98
2 Applications of platelet-rich plasma in dermatology: A criti… (10.3109/09546634.2015.1094178)
Abstract ORCID License
145.46 86
3 Triterpenes with healing activity: A systematic review (10.3109/09546634.2015.1021663)
Abstract ORCID License
140.63 74
4 A randomized, double-blind, placebo-controlled, dose-escalat… (10.3109/09546634.2015.1115819)
Abstract ORCID License
140.63 74
5 Efficacy of sodium hypochlorite (bleach) baths to reduce<i>S… (10.3109/09546634.2015.1067669)
Abstract ORCID License
139.30 71
6 Gabapentin: A promising therapy for uremic pruritus in hemod… (10.3109/09546634.2016.1161161)
Abstract ORCID License
131.11 55
7 Methotrexate in pediatric plaque-type psoriasis: Long-term d… (10.3109/09546634.2014.996515)
Abstract ORCID License
129.93 53
8 Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment o… (10.3109/09546630903401462)
Abstract ORCID License
128.70 51
9 Association between psoriasis and chronic obstructive pulmon… (10.3109/09546634.2015.1107180)
Abstract ORCID License
126.76 48
10 <b>β</b>-Glucan-based cream (containing pleuran isolated fro… (10.3109/09546634.2015.1117565)
Abstract ORCID License
124.71 45
11 Measurement properties of a patient-reported outcome measure… (10.3109/09546634.2015.1114567)
Abstract ORCID License
123.99 44
12 Effectiveness and safety of cyclosporine in pediatric plaque… (10.3109/09546634.2015.1120852)
Abstract ORCID License
123.26 43
13 Long-term effect of early-life supplementation with probioti… (10.3109/09546634.2015.1027168)
Abstract ORCID License
122.51 42
14 Topical tranexamic acid as an adjuvant treatment in melasma:… (10.3109/09546634.2015.1115812)
Abstract ORCID License
122.51 42
15 Use of off-label doses is frequent in biologic therapy for m… (10.3109/09546634.2015.1034070)
Abstract ORCID License
120.96 40
16 Melanoma and non-melanoma skin cancer in psoriatic patients… (10.3109/09546634.2015.1133882)
Abstract ORCID License
120.96 40
17 Efficacy of a novel phosphodiesterase inhibitor, E6005, in p… (10.3109/09546634.2016.1157257)
Abstract ORCID License
119.33 38
18 Intralesional immunotherapy with tuberculin purified protein… (10.3109/09546634.2015.1078871)
Abstract ORCID License
118.48 37
19 Cyclosporine treatment of severe Hidradenitis suppurativa –… (10.3109/09546634.2015.1088128)
Abstract ORCID License
116.72 35
20 Observational case series on adalimumab-induced paradoxical… (10.3109/09546634.2015.1094179)
Abstract ORCID License
115.81 34
21 Correlations among steroid fear, acceptability, usage freque… (10.3109/09546634.2015.1025030)
Abstract ORCID License
114.86 33
22 Spray versus intralesional cryotherapy for keloids (10.3109/09546634.2015.1088129)
Abstract ORCID License
112.89 31
23 The future of lasers in onychomycosis (10.3109/09546634.2015.1066479)
Abstract ORCID License
111.85 30
24 Does replacement of vitamin D reduce the symptom scores and… (10.3109/09546634.2015.1079297)
Abstract ORCID License
111.85 30
25 Demyelinating disorders secondary to TNF-inhibitor therapy f… (10.3109/09546634.2015.1136385)
Abstract ORCID License
111.85 30
26 A double-blinded, randomized, vehicle-controlled study to ac… (10.3109/09546634.2015.1079298)
Abstract ORCID License
110.78 29
27 Serum cytokine and chemokine profiles in patients with alope… (10.3109/09546634.2015.1093591)
Abstract ORCID License
110.78 29
28 An open comparative study of nail drilling as adjunctive tre… (10.3109/09546634.2016.1151856)
Abstract ORCID License
110.78 29
29 Use of<i>Candida</i>antigen injections for the treatment of… (10.3109/09546634.2015.1106436)
Abstract ORCID License
109.68 28
30 Delusions of parasitosis; suggested dialogue between dermato… (10.3109/09546634.2014.996513)
Abstract ORCID License
107.35 26
31 A comparative clinical and mycological study of Nd-YAG laser… (10.3109/09546634.2014.998607)
Abstract ORCID License
107.35 26
32 Effectiveness of erbium:YAG laser and cryosurgery in seborrh… (10.3109/09546634.2015.1024597)
Abstract ORCID License
107.35 26
33 Systemic cyclosporine treatment in severe childhood psoriasi… (10.3109/09546634.2015.1034072)
Abstract ORCID License
107.35 26
34 Clinical features and <i>Staphylococcus… (10.3109/09546634.2015.1093586)
Abstract ORCID License
107.35 26
35 Differences in psoriasis signs and symptom severity between… (10.3109/09546634.2015.1093589)
Abstract ORCID License
107.35 26
36 Rosacea patients seeking advice: Qualitative analysis of pat… (10.3109/09546634.2015.1133881)
Abstract ORCID License
106.12 25
37 Psoriasis patients’ willingness to accept side-effect risks… (10.3109/09546634.2015.1034071)
Abstract ORCID License
104.85 24
38 Objective assessment of isotretinoin-associated cheilitis: I… (10.3109/09546634.2015.1086477)
Abstract ORCID License
104.85 24
39 Treatments for microcystic adnexal carcinoma – A review (10.3109/09546634.2015.1089351)
Abstract ORCID License
104.85 24
40 Different doses of gabapentin formulations for postherpetic… (10.3109/09546634.2016.1163315)
Abstract ORCID License
104.85 24
41 A prospective, randomized, double-blind comparison of an abl… (10.3109/09546634.2014.999020)
Abstract ORCID License
103.52 23
42 Clinical experience with systemic cyclosporine A treatment i… (10.3109/09546634.2015.1115813)
Abstract ORCID License
102.13 22
43 Randomized, double-blind, comparative study on efficacy and… (10.3109/09546634.2015.1119781)
Abstract ORCID License
102.13 22
44 Introduction of dermatome shaving as first line treatment of… (10.3109/09546634.2014.999021)
Abstract ORCID License
100.68 21
45 Evidence-based adverse effects of biologic agents in the tre… (10.3109/09546634.2015.1027167)
Abstract ORCID License
100.68 21
46 Blister roof grafting, cultured melanocytes transplantation… (10.3109/09546634.2015.1034068)
Abstract ORCID License
100.68 21
47 Localized topical steroid use and central serous retinopathy (10.3109/09546634.2015.1136049)
Abstract ORCID License
100.68 21
48 Efficacy, acceptability and cost effectiveness of four thera… (10.3109/09546634.2016.1151855)
Abstract ORCID License
100.68 21
49 Development of clinical prediction models for good or bad re… (10.3109/09546634.2015.1088130)
Abstract ORCID License
99.17 20
50 Efficacy of 5% amorolfine nail lacquer in <i>Neoscytalidium… (10.3109/09546634.2015.1109029)
Abstract ORCID License
99.17 20